Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, Novartis uses innovative science and digital technologies to create transformative treatments in areas of great medical need. In its quest to find new medicines, Novartis consistently rank among the world’s top companies investing in research and development. Novartis products reach nearly 800 million people globally and Novartis is finding innovative ways to expand access to Novartis latest treatments. About 109,000 people of more than 145 nationalities work at Novartis around the world. Find out more at https://www.novartis.com.
NIBR (Novartis Institutes for BioMedical Research), the research organization of Novartis, is a global organization of approximately 6,000 scientists, physicians and business professionals. Among other disease areas and platforms, NIBR has world-leading expertise in the areas of cheminformatics and application of machine learning in drug discovery.